InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ALTERITY THERAPEUTICS LTD

ATHE Clue Score64
Australia Fiscal year ends June CIK 0001131343
$3.12 +1.47% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.12 +141.47% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2017Revenue0.1Net income−7.5Fiscal year 2018Revenue0.2 +51.9%Net income−8.3Fiscal year 2019Net income12.3EPS, diluted−2.00Fiscal year 2020Net income13.5 +9.1%EPS, diluted−1.50Fiscal year 2021Net income15.3 +13.8%EPS, diluted−0.90Fiscal year 2022Net income12.8 −16.1%EPS, diluted−0.53Fiscal year 2023Net income13.8 +7.5%EPS, diluted−0.57Fiscal year 2024Net income−19.1 −238.5%EPS, diluted−0.52Fiscal year 2025Net income−12.1EPS, diluted−0.19
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.1 0.2 n/a n/a n/a n/a n/a n/a n/a
Growth +51.9%
Net income −7.5 −8.3 12.3 13.5 15.3 12.8 13.8 −19.1 −12.1
Growth +9.1% +13.8% −16.1% +7.5% −238.5%
EPS, diluted n/a n/a −2.00 −1.50 −0.90 −0.53 −0.57 −0.52 −0.19

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Net margin
Fiscal year 2017Net margin−5,696.6%Free cash flow margin−4,451.0%Fiscal year 2018Net margin−4,108.8%Free cash flow margin−3,135.4%Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net margin −5,696.6% −4,108.8% n/a n/a n/a n/a n/a n/a n/a
Free cash flow margin −4,451.0% −3,135.4% n/a n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−5.9Capital expenditure−0.0Free cash flow−5.9Fiscal year 2018Operating cash flow−6.2Capital expenditure−0.1Free cash flow−6.3Fiscal year 2019Operating cash flow−14.0Capital expenditure−0.0Free cash flow−14.0Fiscal year 2020Operating cash flow−9.4Capital expenditure−0.0Free cash flow−9.4Fiscal year 2021Operating cash flow−17.3Capital expenditure−0.0Free cash flow−17.3Fiscal year 2022Operating cash flow−12.3Capital expenditure−0.1Free cash flow−12.4Fiscal year 2023Operating cash flow−20.0Capital expenditure−0.0Free cash flow−20.0Fiscal year 2024Operating cash flow−12.6Capital expenditure−0.0Free cash flow−12.6Fiscal year 2025Operating cash flow−11.5
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −5.9 −6.2 −14.0 −9.4 −17.3 −12.3 −20.0 −12.6 −11.5
Capital expenditure −0.0 −0.1 −0.0 −0.0 −0.0 −0.1 −0.0 −0.0 n/a
Free cash flow −5.9 −6.3 −14.0 −9.4 −17.3 −12.4 −20.0 −12.6 n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash21.9Shareholders’ equity23.7Fiscal year 2018Cash15.2Shareholders’ equity16.1Fiscal year 2019Cash14.4Shareholders’ equity16.6Fiscal year 2020Cash9.2Shareholders’ equity7.2Fiscal year 2021Cash28.1Shareholders’ equity30.5Fiscal year 2022Cash34.8Shareholders’ equity35.5Fiscal year 2023Cash15.8Shareholders’ equity−195.1Fiscal year 2024Cash12.6Shareholders’ equity−214.2Fiscal year 2025Cash33.2Shareholders’ equity−225.9
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 21.9 15.2 14.4 9.2 28.1 34.8 15.8 12.6 33.2
Shareholders’ equity 23.7 16.1 16.6 7.2 30.5 35.5 −195.1 −214.2 −225.9

In millions of AUD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of AUD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021† 30 Jun 2021 FY2022 30 Jun 2022 FY2023 30 Jun 2023 FY2024† 30 Jun 2024 FY2025† 30 Jun 2025
Revenue and profit
0.1 0.2 n/a n/a n/a n/a n/a n/a n/a
Growth +51.9%
5.7 6.7 13.0 10.1 12.3 14.7 13.2 18.6 14.4
4.0 4.3 4.3 3.4 6.9 5.5 5.1 4.8 5.5
−7.5 −8.3 −12.3 −13.5 −15.3 −12.8 −13.7 −19.1 −12.1
0.0 0.0 0.0 n/a n/a 0.1 0.1 0.0 0.1
−7.5 −8.3 12.3 13.5 15.3 12.8 13.8 −19.1 −12.1
Growth +9.1% +13.8% −16.1% +7.5% −238.5%
Per share
n/a n/a n/a −1.50 −0.90 −0.53 −0.57 −0.52 −0.19
n/a n/a −2.00 −1.50 −0.90 −0.53 −0.57 −0.52 −0.19
Growth
533.9 533.9 615.8 894.9 1,697 2,406 2,428 3,649 6,397
n/a n/a n/a 894.9 1,697 2,406 2,428 3,649 6,397
Growth +89.6% +41.8% +0.9% +50.3% +75.3%

† The diluted share count jumps at 2021 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Shown in AUD as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 4 of 9 years on file.